Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Objectives

1) Summarize and justify the indications, risks, benefits and alternatives for implementing a course of radiotherapy for each patient.
2) Evaluate and assess the optimal radiation plan in terms of dose and fractionation, radiation field design to optimize tumor cure and minimize expected side effects from treatment and the use of concurrent chemotherapy.

Target Audience

Radiation Oncologists, nurses, physicists, dosimetrists, radiation therapists, and all providers involved patient care in the radiation oncology department.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Michael Dyer, Speaker, has no relevant financial relationships to disclose.

Minh Truong, Course Director and Speaker, has no relevant financial relationships to disclose.

Kimberley Mak, Co-Course Director and Speaker, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.